BARBARA GOODMAN: Open Payments
NPI 1205546900 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 40 payments from 12 companies in 2025. Trend: 2023 $397 · 2024 $664 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $169 |
| ABBVIE INC. | 13 | $136 |
| Vanda Pharmaceuticals Inc. | 1 | $100 |
| Collegium Pharmaceutical, Inc. | 6 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Tris Pharma Inc | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, FANAPT, Jornay PM, COBENFY, SPRAVATO, REXULTI, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
